SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) Fundamental Analysis & Valuation

BIT:1SOBI • SE0000872095

Current stock price

35.98 EUR
+1.02 (+2.92%)
Last:

This 1SOBI.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 1SOBI.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1SOBI was profitable.
  • In the past year 1SOBI had a positive cash flow from operations.
  • In the past 5 years 1SOBI has always been profitable.
  • In the past 5 years 1SOBI always reported a positive cash flow from operatings.
1SOBI.MI Yearly Net Income VS EBIT VS OCF VS FCF1SOBI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B

1.2 Ratios

  • 1SOBI has a better Return On Assets (0.71%) than 67.47% of its industry peers.
  • The Return On Equity of 1SOBI (1.27%) is better than 71.08% of its industry peers.
  • The Return On Invested Capital of 1SOBI (13.73%) is better than 90.36% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1SOBI is below the industry average of 13.21%.
  • The last Return On Invested Capital (13.73%) for 1SOBI is above the 3 year average (9.46%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.71%
ROE 1.27%
ROIC 13.73%
ROA(3y)3.04%
ROA(5y)3.93%
ROE(3y)6.01%
ROE(5y)7.9%
ROIC(3y)9.46%
ROIC(5y)9.35%
1SOBI.MI Yearly ROA, ROE, ROIC1SOBI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.69%, 1SOBI is in the better half of the industry, outperforming 69.88% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1SOBI has declined.
  • 1SOBI has a Operating Margin of 28.37%. This is amongst the best in the industry. 1SOBI outperforms 83.13% of its industry peers.
  • 1SOBI's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of 1SOBI (78.90%) is better than 67.47% of its industry peers.
  • 1SOBI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 28.37%
PM (TTM) 1.69%
GM 78.9%
OM growth 3Y5.61%
OM growth 5Y-0.63%
PM growth 3Y-50.6%
PM growth 5Y-39.72%
GM growth 3Y1.02%
GM growth 5Y0%
1SOBI.MI Yearly Profit, Operating, Gross Margins1SOBI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1SOBI.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1SOBI is creating value.
  • 1SOBI has more shares outstanding than it did 1 year ago.
  • 1SOBI has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1SOBI has been reduced compared to a year ago.
1SOBI.MI Yearly Shares Outstanding1SOBI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1SOBI.MI Yearly Total Debt VS Total Assets1SOBI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • 1SOBI has an Altman-Z score of 3.98. This indicates that 1SOBI is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.98, 1SOBI is doing good in the industry, outperforming 68.67% of the companies in the same industry.
  • The Debt to FCF ratio of 1SOBI is 2.12, which is a good value as it means it would take 1SOBI, 2.12 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.12, 1SOBI belongs to the top of the industry, outperforming 87.95% of the companies in the same industry.
  • A Debt/Equity ratio of 0.14 indicates that 1SOBI is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.14, 1SOBI is doing good in the industry, outperforming 61.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 2.12
Altman-Z 3.98
ROIC/WACC2.05
WACC6.7%
1SOBI.MI Yearly LT Debt VS Equity VS FCF1SOBI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 0.90 indicates that 1SOBI may have some problems paying its short term obligations.
  • The Current ratio of 1SOBI (0.90) is worse than 69.88% of its industry peers.
  • A Quick Ratio of 0.59 indicates that 1SOBI may have some problems paying its short term obligations.
  • 1SOBI's Quick ratio of 0.59 is on the low side compared to the rest of the industry. 1SOBI is outperformed by 78.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.59
1SOBI.MI Yearly Current Assets VS Current Liabilites1SOBI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1SOBI.MI Growth Analysis

3.1 Past

  • The earnings per share for 1SOBI have decreased strongly by -88.99% in the last year.
  • Measured over the past years, 1SOBI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -32.38% on average per year.
  • Looking at the last year, 1SOBI shows a quite strong growth in Revenue. The Revenue has grown by 8.49% in the last year.
  • The Revenue has been growing by 13.10% on average over the past years. This is quite good.
EPS 1Y (TTM)-88.99%
EPS 3Y-49.88%
EPS 5Y-32.38%
EPS Q2Q%32.84%
Revenue 1Y (TTM)8.49%
Revenue growth 3Y14.54%
Revenue growth 5Y13.1%
Sales Q2Q%5.19%

3.2 Future

  • 1SOBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 80.96% yearly.
  • Based on estimates for the next years, 1SOBI will show a quite strong growth in Revenue. The Revenue will grow by 8.72% on average per year.
EPS Next Y1404.9%
EPS Next 2Y335.1%
EPS Next 3Y174.39%
EPS Next 5Y80.96%
Revenue Next Year11.39%
Revenue Next 2Y12.27%
Revenue Next 3Y10.69%
Revenue Next 5Y8.72%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1SOBI.MI Yearly Revenue VS Estimates1SOBI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
1SOBI.MI Yearly EPS VS Estimates1SOBI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

7

4. 1SOBI.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 299.83, the valuation of 1SOBI can be described as expensive.
  • 68.67% of the companies in the same industry are more expensive than 1SOBI, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of 1SOBI to the average of the S&P500 Index (26.86), we can say 1SOBI is valued expensively.
  • Based on the Price/Forward Earnings ratio of 19.85, the valuation of 1SOBI can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, 1SOBI is valued cheaply inside the industry as 83.13% of the companies are valued more expensively.
  • 1SOBI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.39.
Industry RankSector Rank
PE 299.83
Fwd PE 19.85
1SOBI.MI Price Earnings VS Forward Price Earnings1SOBI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • 1SOBI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1SOBI is cheaper than 89.16% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1SOBI indicates a rather cheap valuation: 1SOBI is cheaper than 80.72% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 25.45
EV/EBITDA 8.18
1SOBI.MI Per share data1SOBI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of 1SOBI may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1SOBI's earnings are expected to grow with 174.39% in the coming years.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y335.1%
EPS Next 3Y174.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1SOBI.MI Dividend Analysis

5.1 Amount

  • No dividends for 1SOBI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1SOBI.MI Fundamentals: All Metrics, Ratios and Statistics

SWEDISH ORPHAN BIOVITRUM AB

BIT:1SOBI (3/4/2026, 7:00:00 PM)

35.98

+1.02 (+2.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-05
Earnings (Next)04-27
Inst Owners37.33%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap12.86B
Revenue(TTM)28.24B
Net Income(TTM)478.00M
Analysts80
Price Target41.26 (14.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-123.13%
Min EPS beat(2)-270.86%
Max EPS beat(2)24.59%
EPS beat(4)3
Avg EPS beat(4)-54.43%
Min EPS beat(4)-270.86%
Max EPS beat(4)24.59%
EPS beat(8)7
Avg EPS beat(8)-14.12%
EPS beat(12)8
Avg EPS beat(12)-15.07%
EPS beat(16)11
Avg EPS beat(16)-6.36%
Revenue beat(2)0
Avg Revenue beat(2)-3.75%
Min Revenue beat(2)-4.6%
Max Revenue beat(2)-2.9%
Revenue beat(4)1
Avg Revenue beat(4)-2.12%
Min Revenue beat(4)-4.6%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)2.19%
Revenue beat(12)6
Avg Revenue beat(12)2.8%
Revenue beat(16)10
Avg Revenue beat(16)3.11%
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)-6.72%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-2.48%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 299.83
Fwd PE 19.85
P/S 4.88
P/FCF 25.45
P/OCF 16.08
P/B 3.65
P/tB N/A
EV/EBITDA 8.18
EPS(TTM)0.12
EY0.33%
EPS(NY)1.81
Fwd EY5.04%
FCF(TTM)1.41
FCFY3.93%
OCF(TTM)2.24
OCFY6.22%
SpS7.38
BVpS9.85
TBVpS-2.97
PEG (NY)0.21
PEG (5Y)N/A
Graham Number5.16
Profitability
Industry RankSector Rank
ROA 0.71%
ROE 1.27%
ROCE 15.6%
ROIC 13.73%
ROICexc 14.01%
ROICexgc 566.89%
OM 28.37%
PM (TTM) 1.69%
GM 78.9%
FCFM 19.17%
ROA(3y)3.04%
ROA(5y)3.93%
ROE(3y)6.01%
ROE(5y)7.9%
ROIC(3y)9.46%
ROIC(5y)9.35%
ROICexc(3y)9.64%
ROICexc(5y)9.57%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.12%
ROCE(5y)10.97%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y10.49%
ROICexc growth 5Y5.93%
OM growth 3Y5.61%
OM growth 5Y-0.63%
PM growth 3Y-50.6%
PM growth 5Y-39.72%
GM growth 3Y1.02%
GM growth 5Y0%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 2.12
Debt/EBITDA 0.3
Cap/Depr 31.23%
Cap/Sales 11.17%
Interest Coverage 11.04
Cash Conversion 47.3%
Profit Quality 1132.22%
Current Ratio 0.9
Quick Ratio 0.59
Altman-Z 3.98
F-Score6
WACC6.7%
ROIC/WACC2.05
Cap/Depr(3y)89.13%
Cap/Depr(5y)69.38%
Cap/Sales(3y)15.02%
Cap/Sales(5y)11.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.99%
EPS 3Y-49.88%
EPS 5Y-32.38%
EPS Q2Q%32.84%
EPS Next Y1404.9%
EPS Next 2Y335.1%
EPS Next 3Y174.39%
EPS Next 5Y80.96%
Revenue 1Y (TTM)8.49%
Revenue growth 3Y14.54%
Revenue growth 5Y13.1%
Sales Q2Q%5.19%
Revenue Next Year11.39%
Revenue Next 2Y12.27%
Revenue Next 3Y10.69%
Revenue Next 5Y8.72%
EBIT growth 1Y37.66%
EBIT growth 3Y20.97%
EBIT growth 5Y12.39%
EBIT Next Year72.66%
EBIT Next 3Y26.31%
EBIT Next 5Y16.54%
FCF growth 1Y23.48%
FCF growth 3Y20.42%
FCF growth 5Y38.19%
OCF growth 1Y15.93%
OCF growth 3Y23.24%
OCF growth 5Y11.7%

SWEDISH ORPHAN BIOVITRUM AB / 1SOBI.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1SOBI.MI.


What is the valuation status of SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI). This can be considered as Fairly Valued.


How profitable is SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) stock?

SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) has a profitability rating of 7 / 10.


What is the valuation of SWEDISH ORPHAN BIOVITRUM AB based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SWEDISH ORPHAN BIOVITRUM AB (1SOBI.MI) is 299.83 and the Price/Book (PB) ratio is 3.65.